Skip Navigation

Cardiovascular Research 2003 58(3):721-722; doi:10.1016/S0008-6363(03)00283-9
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nohé, B.
Right arrow Articles by Dieterich, H.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nohé, B.
Right arrow Articles by Dieterich, H.-J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

A different view on human albumin

Boris Nohé* and Hans-Juergen Dieterich

Laboratory for Vascular Biology, Department of Anaesthesiology and Critical Care, University Hospital Tuebingen, Hoppe-Seyler Str. 3, 72076 Tuebingen, Germany

boris.nohe@uni-tuebingen.de

* Corresponding author. Tel.: +49-7071-29-86622; fax: +49-7071-29-5533.

Received 3 December 2002; accepted 11 February 2003

The first 10% of the full text of this article appears below.

With great interest we have read the article by Zhang and Frei on the anti-inflammatory effects of human albumin in the September issue of this journal [1]. They report a downregulation of vascular cell adhesion molecule-1 (VCAM-1) on albumin-treated human aortic endothelial cells which supports our previous results of a reduced . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?